InnovHeart, with locations in Piedmont, Italy, and Boston, Massachusetts, develops transcatheter mitral valve replacement (TMVR) systems to treat patients suffering from mitral valve disease.
The company is currently in clinical trials testing its novel TMVR Saturn Prosthesis, designed to be consistent with the anatomy of the mitral valve. Saturn is a low-profile prosthetic designed for both Trans-apical and Trans-septal delivery.
Che cosa facciamo nel concreto:
Currently we are working mostly with verification and validation and testing activities for the transeptal implantable valves.
Le sfide ingegneristiche:
No transeptal device for mitral valve replacement is currently approved, neither in EU nor in the US.
We are dealing with challenges such as biocompatibility, duration, hydroperformance etc.